Vanguard Total Inflation-Protected Securities ETF (VTP) Stock Price

73.20 ▲ +0.19 (+0.26%)
Open: 72.92 Vol: 36.29K Day's range: 72.92 - 73.2699 Oct 16, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VTP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 73.12▲ 73.15▲ 73.15▲ 72.78▲ 73.08▲
MA10 73.12▲ 73.12▲ 73.12▲ 72.56▲ 74.08▼
MA20 72.83▲ 72.78▲ 72.78▲ 72.94▲ 74.99▼
MA50 72.49▲ 72.57▲ 72.62▲ 74.22▼ 75.85▼
MA100 73.08▲ 73.33▼ 73.52▼ 75.10▼ N/A    
MA200 74.13▼ 74.29▼ 74.40▼ 75.76▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.028▲ 0.048▲ 0.054▲ 0.129▲ -0.270▼
RSI 67.796▲ 66.328▲ 65.106▲ 48.125▼ 33.161▼
STOCH 70.453     83.657▲ 83.657▲ 67.561     10.335▼
WILL %R -5.479▲ -4.762▲ -4.762▲ -15.510▲ -67.885    
CCI 72.598     68.577     68.577     112.923▲ -110.626▼
Latest Filters Detected On VTP
CDL $VTP Engulfing Candlestick Pattern Detected Set Alert
Vanguard Total Inflation-Protected Securities ETF News
Barinthus Biotherapeutics plc: Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments
Monday, June 08, 2026 07:00 AM
Proposed combination with Clywedog Therapeutics Inc. ("Clywedog") progressing towards closing Completed enrollment of 42 planned subjects in the Phase 1 AVALON trial evaluating VTP-1000 in patients ...
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
Wednesday, December 10, 2025 05:00 AM
GERMANTOWN, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) ("Barinthus Bio," or the "Company"), an immunology and inflammation ("I&I") company focused on ...
Arbutus Biopharma Reports Positive Phase 2a Results for Imdusiran in Combination with VTP-300 and Low Dose Nivolumab in Chronic Hepatitis B Patients at EASL 2025
Tuesday, May 06, 2025 05:00 PM
Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...
VTP historical stock data
date open high low close volume
16/10/26 72.92 73.2699 72.92 73.20 36,290
15/10/26 73.12 73.33 73.00 73.01 230,769
14/10/26 72.31 72.7462 72.31 72.67 136,236
13/10/26 72.66 72.66 72.46 72.53 363,100
12/10/26 72.35 72.593 72.35 72.47 39,500
09/10/26 72.36 72.48 72.36 72.48 72,000
08/10/26 72.31 72.58 72.26 72.50 32,700
07/10/26 72.08 72.3824 72.055 72.34 49,952
06/10/26 72.18 72.34 72.13 72.31 91,210
05/10/26 72.20 72.23 72.02 72.10 443,451
Quote Details
52wk Low:71.971
52wk High:79.365
Vol:36.29K
Avg Vol(3m):1.3M
1Y Chng:-4.49%
1M Chng:-2.68%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00